麻豆映画传媒官方app免费下载_国产狂喷潮在线播放_黄色美女性爱喷水视频网_男人的天堂免费观看视频_乱操av一区二区_亚洲黄色av一区_国产高清毛片视频在线播_久久调教亚洲精品

◆ 會議時間：2026年2月26-28日
◆ 會議地點：丹麥 哥本哈根

◆ 會議簡介：

2026年第27屆歐洲婦科腫瘤學大會(ESGO2026)將于2026年2月26-28日在丹麥哥本哈根舉行，會議由歐洲婦科腫瘤學會(ESGO)主辦。歐洲婦科腫瘤學會(ESGO)年會/大會是歐洲規模最大的婦科腫瘤學會議，預計有來自世界各地的2800余名專業人士與會。ESGO大會將是一個獨特的教育體驗，與會者將從超過70個由世界專家主持的涵蓋婦科腫瘤學主要議題的科學會議中受益，會議將使用包括全體會議、最佳口頭和海報會議等多種形式。ESGO2022將為與會者提供一個學習和討論婦科癌癥研究、治療和護理方面的最新醫學和科學進展，以及與來自世界各地的專家和同行建立聯系的機會。

歐洲婦科腫瘤學會（ESGO）成立于1983年，是歐洲領先的婦科癌癥研究組織，由來自歐洲和世界各地的3400多名參與婦科癌癥治療、護理、研究的專業人員組成；ESGO致力于通過預防、卓越宣的護理，高質量的研究和教育，提高歐洲婦科（生殖器官和乳腺）癌癥患者的健康和福祉。ESGO的愿景是：為歐洲所有婦科癌癥患者提供最佳的預防和護理（未經許可禁止復制摘錄轉載本站任何內容-領域國際醫學會議網(lingyuint.com)

ESGO 2026 - 27th European Congress on Gynaecological Oncology
27th Congress of the European Society of Gynaecological Oncology

Date:
February 26-28, 2026

Location:
Copenhagen, Denmark

Organized by:
European Society of Gynaecological Oncology (ESGO)

摘要征文投稿：

點此提交摘要>>>Submit Abstract>>>

Abstracts Topics

• Cervical cancer
• Diagnostics
• Endometrial cancer
• Fertility/Pregnancy
• Miscellaneous
• Ovarian cancer
• Palliative care
• Pathology
• Prevention of gynaecological cancer
• Quality of life after treatment
• Rare Tumours
• Translational research/biomarkers
• Trophoblastic diseases
• Vaginal and vulvar cancer
• Organization of gynaecological cancer care
• Trial in progress
• Patient advocates topic

The Scientific Programme Committee, invited faculty members, and other experts will review the abstracts after the submission deadline in?blind review. To keep transparency, please?DO NOT refer?to institution or hospital where the research took place in the body of the text.

We kindly ask you?NOT?to submit abstracts on following topics:

• Breast cancer
• Non-oncology related abstracts
• No single case reports unless accompanied by translational research or other wider research relating to the case

Instructions for Abstract Authors

• Abstracts can only be submitted via the online form, abstracts submitted by fax or email will not be accepted.
• Abstracts must be submitted in English, using UK English spelling.
• The presenting author of an accepted abstract must register and attend the congress.
• The number of submissions is limited to 3 per presenting author.
• The number of authors is limited to 20 per abstract.
• Provide a short specific title indicating the scientific content of the abstract.

The?background?and goals of the study should appear clearly to the reader. The?methods?need to outline patient group, methods applied, statistical considerations, if applicable.?Results?must contain data (except for Late Breaking abstracts [LBA]- see below), and the?conclusion?should be clearly expressed. The following structure will be required:

• Introduction/Background*
• Methodology
• Results*
• Conclusion*
• Disclosures* (online recording via the submission form)

• The title may not exceed 30 words. PLEASE DO NOT USE CAPITAL LETTERS. The abstract text may not be longer than 300 words (excluding title, authors and disclosures).
• All abbreviations must be defined the first time they appear in the text (but do not define in the title).
• Tables, charts and other graphics (for all in total maximum 1) are permitted and must be in high resolution JPG format.

• Authors should indicate their presentation type preference:
  • Oral presentation preferred
  • Paper poster presentation
  • E-poster only
  • Video presentation
  • Oral presentation in the Young investigator session (only for authors up to 40 years)
  • Place holder for LBA

• The Programme committee reserves the right to decide on the final allocation and presentation method.
• Disclosure of potential?conflict of interest?(e.g., grant support, consultancy, membership on advisory councils, speaker’s bureau) by all authors and source of funding are mandatory. The submitting author is responsible for collecting a Conflict of interest form for all co-authors. All disclosures should be listed within the last 3 years. A COI template is available:?ESGO congress COI form.
• Video presentation?(abstract): Please note the abstract shall be accompanied with the video file. The file should be in .mp4 format with max. size of 500MB and maximum 5 minutes long.
• Abstracts submitted via?commercial entities?will be considered. However, these abstracts should report results from collaborative research conducted by independent (non-commercial) investigators. Investigators, as contributing authors who are employees of commercial entities will only be accepted if independent (academic, clinical and/or scientific) investigators are included as authors. The presenting author should not be an employee of the company.
• Systematic review/meta-analysis?abstracts are acceptable.
• Trials in progress (TiP)?can be accepted as posters/e-posters but will not be accepted as oral presentations. These should not previously have been presented as TiP at an ESGO congress. TiP abstracts have a separate category/topic. It is expected that abstracts submitted as TiP are ongoing trials that have not reached any protocol-specified endpoints for analysis.
• Encore abstracts?(from key data presented at 2025 international meeting as an oral presentation) can be accepted only if they have not been published; with modification and new data, if possible.? In case of a conflict of interest, please do not hesitate to contact us for clarification.
• If several abstracts are based on similar analyses of the same database and one of them is selected for oral presentation, the authors might be asked to combine some/all data into one presentation.
• Case reports?for single cases will not be accepted unless they contain substantial translational work.
• Late Breaking Abstracts (LBA)?are generally reserved for?newly emerging data?that is not available at the time of abstract submission. These could be for initial presentation of results, or significant secondary endpoint analyses. A placeholder LBA?must be?submitted containing the preliminary title, background, methods and type of results that will be presented. LBA will generally not be accepted at a later date unless a shell abstract has been submitted.

Once accepted for presentation, following information is applicable:

• Posters and/or ePosters can inlude QR codes with further information, narration or video.
• The copyright of all data belongs to authors who give permission to ESGO for publication in the IJGC and on eAcademy for registered users.
• The embargo for all abstracts end 10 days prior to the congress and on the first congress day in the case of LBA.
• The embargo for data presented orally ends at the start of the session where the data is presented.

注冊費：

◆ 參會對象：醫生、醫院科室主任/副主任、住院醫師、醫院管理者、醫護人員以及從事該領域研究的科學家、研究人員、醫藥企業代表等等。